Cargando…
The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940176/ https://www.ncbi.nlm.nih.gov/pubmed/29738523 http://dx.doi.org/10.1371/journal.pmed.1002564 |
| _version_ | 1783321063384416256 |
|---|---|
| author | Sinha, Michael S. Kesselheim, Aaron S. |
| author_facet | Sinha, Michael S. Kesselheim, Aaron S. |
| author_sort | Sinha, Michael S. |
| collection | PubMed |
| description | In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission. |
| format | Online Article Text |
| id | pubmed-5940176 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59401762018-05-18 The next forum for unraveling FDA off-label marketing rules: State and federal legislatures Sinha, Michael S. Kesselheim, Aaron S. PLoS Med Editorial In a Guest Editorial, Aaron S. Kesselheim and Michael S. Sinha show how federal and state legislation to allow promotion of drugs for non-approved uses threatens to undermine the FDA's public health mission. Public Library of Science 2018-05-08 /pmc/articles/PMC5940176/ /pubmed/29738523 http://dx.doi.org/10.1371/journal.pmed.1002564 Text en © 2018 Sinha, Kesselheim http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Sinha, Michael S. Kesselheim, Aaron S. The next forum for unraveling FDA off-label marketing rules: State and federal legislatures |
| title | The next forum for unraveling FDA off-label marketing rules: State and federal legislatures |
| title_full | The next forum for unraveling FDA off-label marketing rules: State and federal legislatures |
| title_fullStr | The next forum for unraveling FDA off-label marketing rules: State and federal legislatures |
| title_full_unstemmed | The next forum for unraveling FDA off-label marketing rules: State and federal legislatures |
| title_short | The next forum for unraveling FDA off-label marketing rules: State and federal legislatures |
| title_sort | next forum for unraveling fda off-label marketing rules: state and federal legislatures |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940176/ https://www.ncbi.nlm.nih.gov/pubmed/29738523 http://dx.doi.org/10.1371/journal.pmed.1002564 |
| work_keys_str_mv | AT sinhamichaels thenextforumforunravelingfdaofflabelmarketingrulesstateandfederallegislatures AT kesselheimaarons thenextforumforunravelingfdaofflabelmarketingrulesstateandfederallegislatures AT sinhamichaels nextforumforunravelingfdaofflabelmarketingrulesstateandfederallegislatures AT kesselheimaarons nextforumforunravelingfdaofflabelmarketingrulesstateandfederallegislatures |